Radiopharmaceuticals in Neurological and Psychiatric Disorders

E-ISSN： 2212-3938|3|2|99-107

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.3, Iss.2, 2008-05, pp. : 99-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Astrocytic Adrenoceptors: A Major Drug Target in Neurological and Psychiatric Disorders?

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 3, 2004-06 ,pp. : 239-268

Bentham Science Publishers

Access to resources Recommend Favorite

Ademetionine (S-adenosylmethionine) neuropharmacology: implications for drug therapies in psychiatric and neurological disorders

By Bottiglieri T.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 417-426

Informa Healthcare

Access to resources Recommend Favorite

The DRD2 gene in psychiatric and neurological disorders and its phenotypes

By Noble Ernest P

Pharmacogenomics, Vol. 1, Iss. 3, 2000-08 ,pp. : 309-333

Future Medicine

Access to resources Recommend Favorite

Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders

By Gasior M. Carter R.B. Witkin J.M.

Trends in Pharmacological Sciences, Vol. 20, Iss. 3, 1999-03 ,pp. : 107-112

Elsevier

Access to resources Recommend Favorite

Pharmacology of AMPA/Kainate Receptor Ligands and Their Therapeutic Potential in Neurological and Psychiatric Disorders

By Lees G.J.

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 33-78

Adis International

Access to resources Recommend Favorite